VANCOUVER, British Columbia, Feb. 8, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) will be presenting at the Leerink Swann 2012 Global Healthcare Conference in New York on Wednesday, February 15, 2012, at 4:00 p.m. Eastern Time. Bob Butchofsky, QLT’s President and Chief Executive Officer, will be discussing the Company’s two primary development programs: (i) a synthetic retinoid, QLT091001, for the treatment of Leber Congenital Amaurosis and Retinitis Pigmentosa; and (ii) the Company’s Punctal Plug Delivery System for the treatment of glaucoma.
